Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Saint Louis, MO
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Birmingham,
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Birmingham,
Click here to add this to my saved trials
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Wilmington, DE
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Wilmington, DE
Click here to add this to my saved trials
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Iowa City, IA
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Iowa City, IA
Click here to add this to my saved trials
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Saint Paul, MN
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Efficacy and Safety of Stannsoporfin in Neonates
A Multicenter Study to Evaluate the Efficacy and Safety of Tin Mesoporphyrin (Stannsoporfin) to Reduce the Need for Phototherapy in Term and Near Term Infants.
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Hospital
mi
from
Philadelphia, PA
Efficacy and Safety of Stannsoporfin in Neonates
A Multicenter Study to Evaluate the Efficacy and Safety of Tin Mesoporphyrin (Stannsoporfin) to Reduce the Need for Phototherapy in Term and Near Term Infants.
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Phase IIa, Pilot, Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
mi
from
Los Angeles, CA
Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Phase IIa, Pilot, Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Phase IIa, Pilot, Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
dgd Research, Inc.
mi
from
San Antonio, TX
Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Phase IIa, Pilot, Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
dgd Research, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Homestead, FL
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Homestead, FL
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Great Neck, NY
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Raleigh, NC
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Mobile, AL
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Chandler, AZ
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Chandler, AZ
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Phoenix, AZ
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Scottsdale, AZ
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Anaheim, CA
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Los Angeles, CA
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
San Diego, CA
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Deland, FL
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Deland, FL
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Meridian, ID
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Meridian, ID
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Gurnee, IL
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Gurnee, IL
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Evansville, IN
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Baltimore, MD
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Elkridge, MD
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Elkridge, MD
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Henderson, NV
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Henderson, NV
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Las Vegas, NV
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Albany, NY
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Garden City, NY
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Garden City, NY
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
New York, NY
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Rochester, NY
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Charlotte, NC
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Nashville, TN
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Murray, UT
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Murray, UT
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
West Jordan, UT
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
West Jordan, UT
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Norfolk, VA
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Kenosha, WI
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Kenosha, WI
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Ancona,
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Ancona,
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Birmingham, AL
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Greenbrae, CA
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Lincoln, CA
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Lincoln, CA
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Bradenton, FL
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Hialeah, FL
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Saint Petersburg, FL
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Winston-Salem, NC
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Middleburg Heights, OH
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Smyrna, TN
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Smyrna, TN
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Spring Hill, TN
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Spring Hill, TN
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Dallas, TX
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Fort Worth, TX
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated:  12/31/1969
Mereo Research Site
mi
from
Pearland, TX
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
A Phase IIb Multicentre, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Study Evaluating Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Status: Enrolling
Updated: 12/31/1969
Mereo Research Site
mi
from
Pearland, TX
Click here to add this to my saved trials